Chronic cystoid macular oedema treated with intravitreal dobesilate.

Research paper by Pedro P Cuevas, Luis A LA Outeiriño, Javier J Angulo, Guillermo G Giménez-Gallego

Indexed on: 11 Jul '12Published on: 11 Jul '12Published in: BMJ case reports


Dobesilate is an anti-inflammatory and antipermeability agent. Intravitreal administration of this compound is a therapeutically beneficial agent in the treatment of chronic cystoid macular oedema.